Back to Search Start Over

Comparison of treatment efficacy 1 and 2 years after thyroid remnant ablation with 1110 versus 5550MBq of iodine-131 in patients with intermediate-risk differentiated thyroid cancer.

Authors :
Aghaei, Atena
Ayati, Narjess
Shafiei, Susan
Abbasi, Bita
Zakavi, S. Rasoul
Source :
Nuclear Medicine Communications; Nov2017, Vol. 38 Issue 11, p927-931, 5p
Publication Year :
2017

Details

Language :
English
ISSN :
01433636
Volume :
38
Issue :
11
Database :
Complementary Index
Journal :
Nuclear Medicine Communications
Publication Type :
Academic Journal
Accession number :
125934076
Full Text :
https://doi.org/10.1097/MNM.0000000000000730